Fresenius Medical Care Ventures
Corporate VCBad Homburg · Seed–Late Stage · 7 people tracked
Find your way into Fresenius Medical Care Ventures
1,316 people in our graph share verified history with the Fresenius Medical Care Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
FMCV makes strategic equity investments in start-ups and early-stage healthcare companies, forming partnerships that give Fresenius Medical Care access to new technologies and therapy approaches in its core and complementary businesses. It invests across multiple healthcare sectors including medical devices, pharmaceuticals, digital healthcare, and healthcare services, from seed to later stage depending on strategic fit. Beyond capital, the firm leverages Fresenius Medical Care's resources to help portfolio companies navigate the path of bringing innovation to patients.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website & public directories
What they invest in
from 16 of 16 portfolio companiesHealthtech ×14Medical Devices ×13Digital Health ×8Biotech ×6Hardware ×4Deep Tech ×2AI & Machine Learning ×1IoT ×1
HQs:United States×9Canada×1Switzerland×1Germany×1Israel×1
Investments · 16 tracked
founders shown can be your intro pathBy year:2024 · 12022 · 12 dated
DocGo provides mobile and virtual health services, including medical transportation for hospitals, care gap closure and longitudinal care programs for payers, and population health programs for public health departments.
Digital HealthHealthtechNew York, US
Lee Bienstock(Chief Executive Officer)inNorm Rosenberg(Treasurer and Chief Financial Officer)inStephen Sugrue(Chief Compliance Officer)inBonu Kapoor(Chief Medical Officer of SteadyMD; VP of Clinical Practice & Innovation at DocGo)inHawk Newton(Chief Technology Officer)inEly D. Tendler(General Counsel)
Co-investorsAlpha Ascent Ventures Llc
Humacyte is a regenerative medicine company that develops a bioengineered, human-derived Acellular Tissue Engineered Vessel (ATEV) along with a scalable cell sourcing and manufacturing platform.
BiotechHealthtechMedical DevicesMorrisville, US
Laura E. Niklason(Director)inLaura Niklason, MD, PhD(Founder)inTed Lithgow(Executive Officer)inPaul Boyer(Executive Officer)inCarrie S. Cox(Executive Officer, Director)Dale A. Sander(Chief Financial Officer, Chief Corporate Development Officer and Treasurer)in
Co-investorsFirst In VenturesOberland Capital
Retia Medical develops advanced hemodynamic monitoring devices, including the Argos Cardiac Output Monitor, which uses proprietary algorithms to provide real-time clinical decision support for high-risk patients.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Marc Zemel(Co-Founder and CEO)inRamakrishna Mukkamala(Co-Founder)inJerry Korten(Executive Vice President)inRoger Mecca(Consultative Medical Officer)inAlexander Markovic(Chief Operating Officer)in
Co-investorsRed Cedar
Albutec develops extracorporeal albumin dialysis (ECAD) technology, including its MaxiCycler device with redesigned adsorbent and tubing, to support or replace liver function in patients with acute and acute-on-chronic liver failure.
BiotechHardwareHealthtechMedical DevicesRostock, DE
Katrin Stange(Chief Executive Officer)inJan Stange(Chief Medical Officer)inDipl.-Med. Katrin Stange(Chief Executive Officer)
BioIntelliSense develops scalable physiologic monitoring technology for continuous, proactive patient monitoring aimed at improving clinical outcomes and lowering the cost of care.
Digital HealthHealthtechIoTMedical DevicesGolden, US
James Mault(Executive Officer, Director)inDavid Wang(Executive Officer, Director)inRonald Chwang(Director)Alan Meeker(Director)Larry Leisure(Director)Steve Hess(Director)
Co-investorsBose VenturesCU Healthcare Innovation FundSkyPoint Ventures
eGenesis uses gene editing and genome engineering to develop porcine donor animals for cross-species organ transplantation, addressing organ failure treatment and transplant supply constraints.
BiotechDeep TechMedical Devices
Mike Curtis, Ph.D.(President & Chief Executive Officer)
Co-investorsAlta PartnersAltium CapitalEisai Innovation, Inc.Khosla VenturesLux Capital
BiotechHealthtechMedical DevicesMartinez, US
Michael DiMeo(Executive Officer)inErin Borger(Executive Officer, Director)inRobert S. Ward(Executive Officer, Director)inKeith McCrea(Executive Officer, Director)inGeorge Pitarra(Executive Officer, Director)Kathleen White(Executive Officer)in
Co-investorsCycad Group LLC
MagentaMed develops the Elevate percutaneous Left Ventricular Assist Device (pLVAD), a low-profile, high-flow arterial pump for temporary mechanical circulatory support.
HardwareHealthtechMedical DevicesKadima, IL
Yosi Tuval(MSc – Co-Founder & CTO)Ehud Schwammenthal(MD, PhD – Co-Founder & CMO)inDavid Israeli(MD, MBA – Chairman & CEO)in
Co-investorsALIVE Israel HealthTech FundNew Enterprise Associates (NEA)OrbiMedRA Capital
Memo Therapeutics develops therapeutic antibodies targeting viral infections to improve treatment outcomes for patients with conditions like BKPyV infection in kidney transplant recipients and oncological viral diseases.
BiotechMedical DevicesZurich, CH
Co-investorsKurma PartnersPureos BioventuresYsios CapitalAdjuvant CapitalVerve Venturesredalpine
.jpeg){kind=logo}
Modulim develops microvascular imaging and data solutions that help clinicians assess and manage lower limb health in patients at risk of complications from diabetes, kidney disease, and peripheral arterial disease.
Digital HealthHealthtechMedical DevicesIrvine, US
David Cuccia(Executive Officer, Director)Richard Oberreiter(Executive Officer)Bruce Tromberg(Director)
BoardJoseph Rinehart(Director)Randall Lunn(Director)Andrew Campbell(Director)
Co-investorsCove FundMitsubishi UFJ Capital
Modulim develops spatial frequency domain imaging (SFDI) technology that provides clinicians with microvascular and tissue oxygenation insights for the lower limb, supporting assessment of conditions such as diabetic circulatory complications.
Digital HealthHealthtechMedical DevicesIrvine, US
David J. Cuccia(Founder & Chief Technology Officer)inCharlie Huiner(President & Chief Executive Officer)inAmaan Mazhar(Chief Product Officer)in
Co-investorsPangaea VenturesPangaea Ventures Us Inc.
SafeRide Health provides non-emergency medical transportation (NEMT) through a technology platform and a nationwide network of transport and rideshare providers, connecting patients — largely Medicare Advantage and Medicaid members — to healthcare appointments.
Digital HealthHealthtechMobility & Transportation
Robbins Schrader(Chief Executive Officer, Co-Founder)Ben Salter(Chief Product Officer, Co-Founder)inWhit Schrader(VP of Ops Transformation, Co-Founder)in
Co-investorsAmplify.LABonfire VenturesFCA Venture PartnersHatteras Venture PartnersHDS CapitalLayout Ventures+5 more
Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine.
BiotechDeep TechHealthtechMedical DevicesEdina, US
Jay Katarincic(Founder, Stimdia Medical; Director, Draper Triangle Ventures)inJim Bullock(Founder, Stimdia Medical; Board Chairman)Patrick Wethington(Executive Officer, Director)inAllen Meacham(President and Chief Executive Officer)inBrad Swatfager(Chief Financial Officer)Kristen Lechleiter(Vice President, Clinical and Regulatory Affairs)in
Co-investorsSolas BioVentures
Lucet (formerly Tridiuum) combines technology and clinical expertise to improve access to behavioral and mental health care, connecting people to appropriate providers and services.
Digital HealthHealthtechMental HealthPhiladelphia, US
Grant Grissom(Executive Officer, Director)Paul Castaldo(Mr. Castaldo is the Chief Operating Officer of the Issuer.)Mark A. Redlus(Executive Officer, Director)Martin Nankin(Executive Officer, Director)Mark Anthony(Executive Officer, Director)Edward Camarota(Executive Officer)in
Co-investorsBaleon CapitalMartinson Ventures
Vectorious Medical Technologies develops implantable sensing platforms designed to deliver clinical information for patient therapies.
Digital HealthHardwareHealthtechMedical Devices
Co-investorsBroadview VenturesChampel CapitalGEOC
Exits · 3
2 IPOs · 1 acquisitionsDocgoNASDAQ: DCGOHumacyteNASDAQ: HUMAMemo Therapeuticsacq. by Clementia
Portfolio news
latest coverage across their companies
Humacyte · stocktitan.net · Aug 12, 2026
SafeRide Health · trysignalbase.com · Jul 28, 2026
Memo Therapeutics · investing.com · Jul 22, 2026
ExThera Medical · napavalleyregister.com · Mar 6, 2026
BioIntelliSense · salestools.io · Sep 10, 2025
Frequently asked questions
- How many investments has Fresenius Medical Care Ventures made?
- Fresenius Medical Care Ventures has 16 tracked investments, 3 of which have exited.
- What stage does Fresenius Medical Care Ventures invest at?
- Fresenius Medical Care Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Fresenius Medical Care Ventures focus on?
- Fresenius Medical Care Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Fresenius Medical Care Ventures located?
- Fresenius Medical Care Ventures is headquartered in Bad Homburg, DE.
- Who does Fresenius Medical Care Ventures co-invest with?
- Fresenius Medical Care Ventures most often shares deals with New Enterprise Associates (NEA), Alpha Ascent Ventures Llc, Khosla Ventures, among 34 tracked co-investors.
Media · Podcasts & interviews
from their channelResearch in Brief: Personalizing meal planning for people with chronic kidney disease
Fresenius Medical Care
Research in Brief: Why lean tissue index matters in HDF | FME
Fresenius Medical Care
Research in Brief: Immunosuppressive therapies in kidney transplant recipients | FME
Fresenius Medical Care
Research in Brief: Population Characteristics in Randomized Trials for HDF | FME
Fresenius Medical Care
Artful Resilience: Samroeng Getlim's Story | Life on Dialysis – FME Asia Pacific
Fresenius Medical Care
A new beginning, a future awaiting: Fatin Adibah’s Story | Life on Dialysis – FME Asia Pacific
Fresenius Medical Care
Similar investors
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.
Bay City Capital is a venture capital firm founded in 1997 that has raised five venture funds totaling $1.3 billion in capital commitments and invested in more than 100 companies worldwide.
Gilde Healthcare is a specialist investment firm managing healthcare and climate-focused funds across venture & growth, and private equity strategies with a transatlantic team of sector specialists.
Clal Biotechnology Industries (TASE: CBI) is an Israeli life sciences investment firm listed on the Tel Aviv Stock Exchange, focused on identifying and developing ventures that create proprietary solutions for unmet medical needs.